Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant
Authors:
- Mei ZhengMZMei Zheng
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Vaccination with hemagglutinin or neuraminidase DNA protects BALB/c mice against influenza virus infection in presence of maternal antibodyBMC Infectious Diseases, 2007
- Mutant influenza A virus nucleoprotein is preferentially localized in the cytoplasm and its immunization in mice shows higher immunogenicity and cross-reactivityVaccine, 2007
- Matrix Protein 2 Vaccination and Protection against Influenza Viruses, Including Subtype H5N1Emerging Infectious Diseases, 2007
- Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccinationVaccine, 2007
- Immunoglobulin A antibodies against internal HIV-1 proteins neutralize HIV-1 replication inside epithelial cellsVirology, 2006
- Rotavirus Anti-VP6 Secretory Immunoglobulin A Contributes to Protection via Intracellular Neutralization but Not via Immune ExclusionJournal of Virology, 2006
- Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c miceBiochemical and Biophysical Research Communications, 2006
- The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protectionVaccine, 2006
- Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M geneVaccine, 2001
- InfluenzaThe Lancet, 1999